Literature DB >> 26018873

Effects of Pu-erh tea aqueous extract (PTAE) on blood lipid metabolism enzymes.

Liang Zeng1, Jingna Yan, Liyong Luo, Dongying Zhang.   

Abstract

Disorders of blood lipid metabolism are the primary risk factors for many diseases. Recently, the effect of Pu-erh tea on blood lipid metabolism has received increasing attention. However, the mechanism underlying its ability to regulate blood lipid metabolism is unclear. We set out to study this through assessing the effects of Pu-erh tea aqueous extract (PTAE) on the central enzymes of blood lipid metabolism, including lipoprotein-associated phospholipase A2 (Lp-PLA2), lecithin: cholesterol acyltransferase (LCAT), 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) and pancreatic lipase (PL). We find that the Lp-PLA2, HMRG and PL activities are inhibited by PTAE in a dose-dependent manner and that the LCAT activity tends to increase with increasing PTAE concentrations. Lineweaver-Burk plot analyses reveal that PTAE acts as a competitive inhibitor for HMGR and PL and as a noncompetitive inhibitor for Lp-PLA2. Moreover, we determine that its active ingredients include catechins, gallic acid, caffeine, free amino acids, and soluble sugar. However, the effect of each ingredient and whether any of them have synergistic effects are still unknown. The results suggest that Pu-erh tea has a potent ability to regulate blood lipid metabolism and knowledge of the mechanisms provides insights into its potential therapeutic application as an alternative hypolipidemic drug.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26018873     DOI: 10.1039/c5fo00362h

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  8 in total

1.  Theabrownin from Pu-erh tea together with swinging exercise synergistically ameliorates obesity and insulin resistance in rats.

Authors:  Enkai Wu; Tingting Zhang; Chao Tan; Chunxiu Peng; Yusuf Chisti; Qiuping Wang; Jiashun Gong
Journal:  Eur J Nutr       Date:  2019-07-04       Impact factor: 5.614

2.  Therapeutic management of immune-mediated necrotizing myositis.

Authors:  Emma Weeding; Eleni Tiniakou
Journal:  Curr Treatm Opt Rheumatol       Date:  2021-03-29

3.  Pu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis In Vitro.

Authors:  Titi Liu; Shihua Ding; Dan Yin; Xiangdan Cuan; Chuanqi Xie; Huanhuan Xu; Xuanjun Wang; Jun Sheng
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

4.  Ripe and Raw Pu-Erh Tea: LC-MS Profiling, Antioxidant Capacity and Enzyme Inhibition Activities of Aqueous and Hydro-Alcoholic Extracts.

Authors:  Gabriella Roda; Cristina Marinello; Anita Grassi; Claudia Picozzi; Giancarlo Aldini; Marina Carini; Luca Regazzoni
Journal:  Molecules       Date:  2019-01-29       Impact factor: 4.411

Review 5.  Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review.

Authors:  Guo-Yi Tang; Xiao Meng; Ren-You Gan; Cai-Ning Zhao; Qing Liu; Yi-Bin Feng; Sha Li; Xin-Lin Wei; Atanas G Atanasov; Harold Corke; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2019-12-08       Impact factor: 5.923

6.  Anti-Obesity Effect of Theabrownin from Dark Tea in C57BL/6J Mice Fed a High-Fat Diet by Metabolic Profiles through Gut Microbiota Using Untargeted Metabolomics.

Authors:  Hang-Yu Li; Si-Yu Huang; Ruo-Gu Xiong; Si-Xia Wu; Dan-Dan Zhou; Adila Saimaiti; Min Luo; Hui-Lian Zhu; Hua-Bin Li
Journal:  Foods       Date:  2022-09-27

7.  Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.

Authors:  Gitte S Jensen; Joni L Beaman; Yi He; Zhixin Guo; Henry Sun
Journal:  Clin Interv Aging       Date:  2016-03-24       Impact factor: 4.458

8.  Characterizing relationship between chemicals and in vitro bioactivities of teas made by six typical processing methods using a single Camellia sinensis cultivar, Meizhan.

Authors:  Guanhua Xie; Jingna Yan; Anxia Lu; Jirui Kun; Bei Wang; Chengda Song; Huarong Tong; Qing Meng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.